These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35074149)

  • 1. TB free India: Reaching the unreached tribal population under National Tuberculosis Elimination Programme.
    Bhat J; Rao R; Kumar R; Yadav R; Singh P; Rao VG; Das A
    Indian J Tuberc; 2022 Jan; 69(1):4-7. PubMed ID: 35074149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Research on tuberculosis in tribal areas in India: A systematic review.
    Rao VG; Muniyandi M; Bhat J; Yadav R; Sharma R
    Indian J Tuberc; 2018 Jan; 65(1):8-14. PubMed ID: 29332655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knowledge about tuberculosis among tribal population in Kerala in the backdrop of TB elimination goal by 2025.
    Nair SB; Krishnan AKI; Thomas B
    Indian J Tuberc; 2023 Jan; 70(1):77-86. PubMed ID: 36740322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revisions in TB programme - boon or bane? A qualitative study exploring barriers and facilitators among health care workers in private and public sector, Kerala.
    Mathew G; Kumar SCS; Cherian KM; Issac N; Benjamin AI
    Indian J Tuberc; 2021 Jul; 68(3):356-362. PubMed ID: 34099201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of Revised National Tuberculosis Control Programme (RNTCP) in tribal areas in India.
    Muniyandi M; Rao VG; Bhat J; Yadav R
    Indian J Med Res; 2015 May; 141(5):624-9. PubMed ID: 26139780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating TB diagnostic costs incurred under the National Tuberculosis Elimination Programme: a costing study from Tamil Nadu, South India.
    Muniyandi M; Lavanya J; Karikalan N; Saravanan B; Senthil S; Selvaraju S; Mondal R
    Int Health; 2021 Dec; 13(6):536-544. PubMed ID: 33570132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tuberculosis in Asia].
    Kekkaku; 2002 Oct; 77(10):693-7. PubMed ID: 12440145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Declining tuberculosis prevalence in Saharia, a particularly vulnerable tribal community in Central India: evidences for action.
    Rao VG; Bhat J; Yadav R; Sharma RK; Muniyandi M
    BMC Infect Dis; 2019 Feb; 19(1):180. PubMed ID: 30786860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the impact of COVID-19 management on the workload of human resources working in India's National Tuberculosis Elimination Program.
    Mergenthaler C; Bhatnagar A; Dong D; Kumar V; Lakis C; Mutasa R; Dapkekar S; Sahore A; Surendran S; Fritsche G; Sachdeva KS; Dieleman M
    BMC Health Serv Res; 2024 Aug; 24(1):907. PubMed ID: 39113002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategy and way forward for TB elimination.
    Gupta D
    Indian J Tuberc; 2018 Jan; 65(1):4-5. PubMed ID: 29332646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National TB elimination programme - What has changed.
    Khanna A; Saha R; Ahmad N
    Indian J Med Microbiol; 2023; 42():103-107. PubMed ID: 36402676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. India marching towards TB elimination: How far we are.
    Roy P; Das A; Panda A; T S; Priyadarshani A; Patro BK
    Indian J Tuberc; 2024 Apr; 71(2):213-218. PubMed ID: 38589126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STEPS - a patient centric and low-cost solution to ensure standards of TB care to patients reaching private sector in India.
    Rakesh PS; Balakrishnan S; Sunilkumar M; Alexander KG; Vijayan S; Roddawar V; Pramod Kumar PP; Kailash J; Kunoor A; Rajiv M; John A; Ramachandran R
    BMC Health Serv Res; 2022 Jan; 22(1):2. PubMed ID: 34974843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extensively drug-resistant tuberculosis treated with bedaquiline: A case report in the particularly vulnerable tribal group of Madhya Pradesh, India.
    Mishra P; Sharma R; Yadav R; Bansal G; Rao VG; Bhat J
    Indian J Public Health; 2021; 65(3):318-320. PubMed ID: 34558500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addressing poverty through disease control programmes: examples from Tuberculosis control in India.
    Kamineni VV; Wilson N; Das A; Satyanarayana S; Chadha S; Sachdeva KS; Chauhan LS
    Int J Equity Health; 2012 Mar; 11():17. PubMed ID: 22449205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Competency based medical education as an accelerator to end tuberculosis (End TB) in India.
    Sharma N; Arora E; Lahariya C; Chopra KK
    Indian J Tuberc; 2024 Jan; 71(1):7-11. PubMed ID: 38296393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in Tuberculosis Mortality Across India: Improvements Despite the COVID-19 Pandemic.
    Varshney K; Patel H; Kamal S
    Cureus; 2023 Apr; 15(4):e38313. PubMed ID: 37261163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-administered tuberculosis treatment outcomes in a tribal population on the indo-myanmar border, Nagaland, India.
    Das M; Isaakidis P; Shenoy R; Anicete R; Sharma HK; Ao I; Osah K; Mansoor H; Saranchuk P; Abraham S
    PLoS One; 2014; 9(9):e108186. PubMed ID: 25259868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuberculosis notification: An inquiry among private practitioners in Pimpri-Chinchwad municipal corporation area of Maharashtra, India.
    Sahasrabudhe T; Barthwal M; Sawant T; Ambike S; Jagtap J; Hande S; Atre S
    Indian J Tuberc; 2022 Jan; 69(1):73-78. PubMed ID: 35074154
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.